AMANDA WILLARD: Open Payments
NPI 1174305098 · INTERLACHEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $143 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 1 | $64 |
| ACADIA Pharmaceuticals Inc | 2 | $48 |
| ABBVIE INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $38 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
| Novo Nordisk Inc | 1 | $15 |
Products named: QUTENZA, DAYBUE, MOUNJARO, QULIPTA, SHINGRIX, PREVNAR 20, Cologuard Collection Kit, VRAYLAR.
Industry payments across FL — which companies pay providers there.
